|
||
| |||||||
|
Commercial Opportunities, Legal Trends, & Technology Analyses By: Antoun Nabhan, J.D. and Colleagues Published: March, 2003 150+ Pages, 20+ Exhibits, 16 Companies Profiled The cell-based assays market is expected to grow to several hundred million dollars, at a brisk double-digit growth rate Cell-based assay usage and spending are growing within pharmaceutical and biotechnology companies - driven in large part by the deluge of drug targets derived from genomics and proteomics. Large pharmaceutical companies are seeking to perform screens in cell-based systems because they promise accurate whole cell data representative of the physiological condition. Tool vendors are conscious of this growing need and are on the lookout for technologies designed to measure and automate these cell-based systems in order to become leaders in this arena. These two factors are creating a real interest in, and need for, cell-based assays.
D&MD's Cell-based Assays Report is the only market and industry analyses written by insiders in this arena. This comprehensive Report provides an overview of the industry, qualitative analysis of the market, and a quantitative examination of the market opportunity (in various sub-sectors of cell-based assays). We also examine the intellectual property issues implicit in the development and use of cell-based assays. This Report Will Help You: > Identify viable technology drivers through a comprehensive analysis of the emerging technology platforms within this market > Discover burgeoning market opportunities through a demand-side (bottom-up) market model of the cell-based assays marketplace in different target areas > Recognize the growth and dynamics of the cell-based space through a market model demonstrating the qualitative analysis of this industry, the growth drivers, and emerging trends > Address possible legal obstacles by learning about the legal issues in cell-based technologies, such as ownership of engineered cell lines, content derived there from, and legal hooks for value capture > Focus on the key up-and-coming companies in cell-based assays via extensive profiles of vendors of tools and technologies, those looking to enter, and those making strategic moves. This Report Will Answer These Crucial Industry Questions: What potential opportunities are available within the cell-based assays market? Who and what are the drivers of growth and trends within this space? What are the main ingredients for winning market share? How do I successfully move through the legal quandary presented by the commercialization of cell-based assays? How can cell-based assays be used to address problems in the drug discovery paradigm? What are the major cell-based assays vendors currently doing? --------------------------------------------- In-depth Company Profiles Acumen Bioscience Akceli Amersham Biosciences Applied Biosystems BD Biosciences Clontech BioImage A/S Cellomics DiscoveRx Euroscreen Invitrogen Odyssey Pharmaceuticals PanVera, LLC PerkinElmer Life Sciences (PKI) Sangamo Stratagene Virtual Arrays Publisher: Drug and Market Development To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a67
|
|
|
